DEPLOYDatabase

Deployment

GENE.01 at United States (multiple hotel chains)

GENE.01 is Generative Bionics' first humanoid robot concept, unveiled at CES 2026 in collaboration with AMD. It features full-body tactile sensing (distributed tactile skin), AMD CPUs/GPUs with edge processing, and a Physical AI architecture where intelligence is distributed through the body. With ~40-60 DOF, ~170cm height, and ~60-80kg weight, it targets industrial manufacturing and logistics. Commercial production is expected Q4 2026.

GENE.01 by Generative Bionics · Unverified · Humanoids

Track GENE.01 at United States (multiple hotel chains)

Recent coverage

See all coverage →

Commercial product — available for purchase in this market.

Exposure

Customer segment
manufacturing
Scale tier
pilot lt10

Each exposure value carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Safety record

No incidents on record for GENE.01 at United States (multiple hotel chains).

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Unverifiedhow tiers work →
Last updated
2026-08-20
Model
GENE.01
Company
Generative Bionics
Location
United States (multiple hotel chains)
Operator
Generative Bionics
Status
operational
Operator type
maker operated
Scale at site
2 to 10 units
Site environment
indoor
Location precision
city centroid
First seen
2024-06-01
ID
d315b544-dbf1-4381-8820-99f2eddbf4fc

Timeline

  1. Jun 2024
    First recorded
    GENE.01 first documented operating at United States (multiple hotel chains).
  2. Aug 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Operates worldwide

GENE.01 is deployed globally rather than at a single verified site, so there is no map pin.

Free to use on your site, with a link back to DEPLOY.

GENE.01 operates in United States (multiple hotel chains). Explore the full verified map:

Methodology: Claimed (not independently verified) · no sources on file · last reviewed 2026-08-20

Verification posture

Claimed (not independently verified)

Low confidence

Review state

Stable

Last reviewed 2026-08-20

Maturity + lifecycle

Maturity stage: pilot

Lifecycle: active

Architectural position

Cohort: humanoid

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for GENE.01 at United States (multiple hotel chains).

Common questions

What is the GENE.01 deployment at United States (multiple hotel chains)?
GENE.01, built by Generative Bionics, is recorded as a deployment at United States (multiple hotel chains) on the DEPLOY registry. Generative Bionics operates the deployment directly.
Who operates GENE.01 at United States (multiple hotel chains)?
Generative Bionics, the manufacturer of GENE.01, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the GENE.01 deployment at United States (multiple hotel chains) go live?
The deployment is recorded as starting June 1, 2024 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the GENE.01 deployment at United States (multiple hotel chains)?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces